DB17911ExperimentalGene Therapies
CEQ508 is a Live Attenuated E. Coli Expressing Beta Catenin ShRNA currently being investigated to treat Familial Adenomatous Polyposis.
- Code names
- CEQ508
Which companies are running trials of CEQ508, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account